đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
The purpose of this study is to determine if the addition of daratumumab to...
Status
Completed
Location
Beijing Chaoyang Hospital
Start Date
2017-11-23
Trial ID
NCT03217812
Treatments Being Tested
The purpose of this study is to evaluate the clinical benefit of subcutaneo...
Status
Completed
Location
Cancer Center of Central Connecticut - Southington
Start Date
2018-04-26
Trial ID
NCT03412565
Treatments Being Tested
The goal of this Phase 2, open-label, multicenter, non-randomized pilot stu...
Status
Active Not Recruiting
Location
Hospital Germans Trials i Pujol
Start Date
2023-09-21
Trial ID
NCT05849610
Treatments Being Tested
This is a prospective and single arm clinical study. The goal of this clini...
Status
Unknown
Location
The First Affiliated Hospital of Wenzhou Medical University
Start Date
2024-03-01
Trial ID
NCT06455748
Treatments Being Tested
This is a single-arm, phase II, open-label trial to investigate the effects...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2021-09-10
Trial ID
NCT04782687
Treatments Being Tested
The purpose of this study is to compare the efficacy (rate of very good par...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-05-31
Trial ID
NCT03871829
The purpose of this study is to look at the safety, tolerability, and serum...
Status
Recruiting
Location
University of Maryland Greenebaum Comprehensive Cancer Center
Start Date
2025-10-23
Trial ID
NCT07075510
Treatments Being Tested
This is a single-arm study of daratumumab in metastatic non-small cell lung...
Status
Completed
Location
NYU Langone Health
Start Date
2023-06-01
Trial ID
NCT05807048
Treatments Being Tested
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences /ID# 243096
Start Date
2022-10-20
Trial ID
NCT05259839
Treatments Being Tested